risperidone has been researched along with Psychoses, Drug in 54 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The safety and efficacy of the first long-acting injectable atypical antipsychotic, risperidone, were assessed in stable patients with schizophrenia switched from oral antipsychotic medications." | 9.11 | Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics. ( Berry, SA; Eerdekens, E; Eerdekens, M; Lindenmayer, JP, 2004) |
| "Sibutramine is a serotonin and norepinephrine reuptake intake inhibitor approved for the management of obesity." | 5.35 | Catatonia and psychosis associated with sibutramine: a case report and pathophysiologic correlation. ( Lee, J; Lee, TS; Teoh, T, 2008) |
| "The safety and efficacy of the first long-acting injectable atypical antipsychotic, risperidone, were assessed in stable patients with schizophrenia switched from oral antipsychotic medications." | 5.11 | Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics. ( Berry, SA; Eerdekens, E; Eerdekens, M; Lindenmayer, JP, 2004) |
| " Auditory hallucinations had developed 25 years previously, for which haloperidol had been prescribed." | 3.74 | Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam. ( Inada, T; Oda, T; Yamamoto, N, 2007) |
| "Risperidone, a novel neuroleptic with approximately equal D2 and 5HT2A receptor blocking properties, has been used to treat drug-related hallucinations in patients with Parkinson's disease." | 3.70 | Risperidone treatment of drug-related psychosis in patients with parkinsonism. ( Leopold, NA, 2000) |
| "Risperidone-treated patients reported significantly greater METH craving reductions (p<0." | 2.82 | Aripiprazole and Risperidone for Treatment of Methamphetamine-Associated Psychosis in Chinese Patients. ( Chawarski, MC; Chen, H; Hao, W; Schottenfeld, RS; Wang, G; Xu, Z; Zhang, S; Zhang, Y, 2016) |
| "Risperidone treatment did not adversely affect symptoms specific to Parkinson's disease, as assessed by the Unified Parkinson's Disease Rating Scale (UPDRS)." | 2.69 | Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: an open pilot trial. ( De Deyn, PP; Hildebrand, K; Mendis, T; Mohr, E, 2000) |
| " The problem of low exposure of 18b was effectively addressed by its conversion to an acetate prodrug 25b, which upon oral dosing resulted in an improved pharmacokinetic profile (Cmax = 359 ng." | 1.42 | Design, Synthesis, and Pharmacological Evaluation of 5,6-Disubstituted Pyridin-2(1H)-one Derivatives as Phosphodiesterase 10A (PDE10A) Antagonists. ( Bajpai, M; Dahale, DH; Gudi, GS; Gullapalli, S; Gupta, PK; Jadhav, SB; Khairatkar-Joshi, N; Kummari, S; Lingam, VS; Mindhe, AS; Pattem, R; Rathi, VE; Sapalya, RS; Shah, DM; Shingote, YB; Thakur, RR; Thomas, A, 2015) |
| "Risperidone was started to treat psychotic symptoms." | 1.38 | Severe psychotic exacerbation during combined treatment with aripiprazole/haloperidol after prior treatment with risperidone. ( Grohmann, R; Holl, AK; Letmaier, M; Painold, A; Vergin, H, 2012) |
| "Risperidone is an effective short-term pharmacologic agent for controlling steroid-related psychiatric adverse effects when cessation or dose reduction of steroid therapy is not an option." | 1.36 | Concurrent treatment of steroid-related mood and psychotic symptoms with risperidone. ( Dahl, G; Shaw, RJ; Tzuang, D; Ularntinon, S, 2010) |
| "Sibutramine is a serotonin and norepinephrine reuptake intake inhibitor approved for the management of obesity." | 1.35 | Catatonia and psychosis associated with sibutramine: a case report and pathophysiologic correlation. ( Lee, J; Lee, TS; Teoh, T, 2008) |
| " Clinicians should attempt to treat patients with the lowest effective dosage of medication for the briefest therapeutic period to minimize the risks of adverse reactions." | 1.31 | Metoclopramide-induced supersensitivity psychosis. ( Lu, ML; Pan, JJ; Shen, WW; Su, KP; Teng, HW, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (22.22) | 18.2507 |
| 2000's | 23 (42.59) | 29.6817 |
| 2010's | 16 (29.63) | 24.3611 |
| 2020's | 3 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Lingam, VS | 1 |
| Dahale, DH | 1 |
| Rathi, VE | 1 |
| Shingote, YB | 1 |
| Thakur, RR | 1 |
| Mindhe, AS | 1 |
| Kummari, S | 1 |
| Khairatkar-Joshi, N | 1 |
| Bajpai, M | 1 |
| Shah, DM | 1 |
| Sapalya, RS | 1 |
| Gullapalli, S | 1 |
| Gupta, PK | 1 |
| Gudi, GS | 1 |
| Jadhav, SB | 1 |
| Pattem, R | 1 |
| Thomas, A | 1 |
| Vázquez-Bourgon, J | 1 |
| Ortiz-García de la Foz, V | 1 |
| Gómez-Revuelta, M | 1 |
| Mayoral-van Son, J | 1 |
| Juncal-Ruiz, M | 1 |
| Garrido-Torres, N | 1 |
| Crespo-Facorro, B | 1 |
| Dhir, S | 1 |
| Khalid, Z | 1 |
| Salcedo, J | 1 |
| Shanbour, A | 1 |
| Yadav, P | 1 |
| Stigall, K | 1 |
| Johnson, HE | 1 |
| Rayapati, AO | 1 |
| Chopra, N | 1 |
| Kanahara, N | 2 |
| Yoshimura, K | 2 |
| Nakamura, M | 1 |
| Oda, Y | 1 |
| Watanabe, M | 1 |
| Iyo, M | 3 |
| Seeman, MV | 1 |
| Shah, UR | 1 |
| Vu, C | 1 |
| Thomas, R | 1 |
| Hartman, DW | 1 |
| Sharma, TR | 1 |
| Farnia, V | 1 |
| Shakeri, J | 1 |
| Tatari, F | 1 |
| Juibari, TA | 1 |
| Yazdchi, K | 1 |
| Bajoghli, H | 1 |
| Brand, S | 1 |
| Abdoli, N | 1 |
| Aghaei, A | 1 |
| Maćkowiak, M | 1 |
| Guzik, R | 1 |
| Dudys, D | 1 |
| Bator, E | 1 |
| Wędzony, K | 1 |
| Chen, KJ | 1 |
| Lu, ML | 2 |
| Shen, WW | 2 |
| Hsu, CC | 1 |
| Lin, CJ | 1 |
| Lu, T | 1 |
| Hu, LY | 1 |
| Wang, G | 1 |
| Zhang, Y | 1 |
| Zhang, S | 1 |
| Chen, H | 1 |
| Xu, Z | 1 |
| Schottenfeld, RS | 1 |
| Hao, W | 1 |
| Chawarski, MC | 1 |
| Kimura, H | 1 |
| Sasaki, T | 1 |
| Komatsu, N | 1 |
| Ishige, M | 1 |
| Muneoka, K | 1 |
| Ino, H | 1 |
| Yamanaka, H | 1 |
| Suzuki, T | 1 |
| Komatsu, H | 1 |
| Watanabe, H | 1 |
| Shimizu, E | 1 |
| Peterson, E | 1 |
| Stoebner, A | 1 |
| Weatherill, J | 1 |
| Kutscher, E | 1 |
| Dogangun, B | 1 |
| Bolat, N | 1 |
| Rustamov, I | 1 |
| Kayaalp, L | 1 |
| Thapa, R | 1 |
| Biswas, B | 1 |
| Bansal, V | 1 |
| Kumar, S | 1 |
| Mowar, A | 1 |
| Sharma, S | 1 |
| Gupta, S | 1 |
| Koul, S | 1 |
| Bhan-Kotwal, S | 1 |
| Jenkins, HS | 1 |
| Carmaciu, CD | 1 |
| Przekop, P | 1 |
| Lee, T | 1 |
| Freeman, SA | 1 |
| Schnider, A | 1 |
| Guggisberg, A | 1 |
| Nahum, L | 1 |
| Gabriel, D | 1 |
| Morand, S | 1 |
| Ularntinon, S | 1 |
| Tzuang, D | 1 |
| Dahl, G | 1 |
| Shaw, RJ | 1 |
| Ekinci, O | 1 |
| Sabuncuoglu, O | 1 |
| Dada, MU | 1 |
| Oluwole, L | 1 |
| Obadeji, A | 1 |
| Ajayi, OA | 1 |
| Letmaier, M | 1 |
| Painold, A | 1 |
| Holl, AK | 1 |
| Grohmann, R | 1 |
| Vergin, H | 1 |
| Fullajtar, M | 1 |
| Ferencz, C | 1 |
| Pan, JJ | 1 |
| Teng, HW | 1 |
| Su, KP | 1 |
| Lindenmayer, JP | 1 |
| Eerdekens, E | 1 |
| Berry, SA | 1 |
| Eerdekens, M | 1 |
| Eren, I | 1 |
| Ozcankaya, R | 1 |
| Altinyazar, V | 1 |
| Lambert, M | 1 |
| Conus, P | 1 |
| Lubman, DI | 1 |
| Wade, D | 1 |
| Yuen, H | 1 |
| Moritz, S | 1 |
| Naber, D | 1 |
| McGorry, PD | 1 |
| Schimmelmann, BG | 1 |
| Ahn, MS | 1 |
| Sims, KB | 1 |
| Frazier, JA | 1 |
| Fischer, RB | 1 |
| Quarantini, LC | 1 |
| Cruz, SC | 1 |
| Batista-Neves, SC | 1 |
| Paraná, R | 1 |
| Miranda-Scippa, A | 1 |
| Bressan, RA | 1 |
| Marchesi, C | 1 |
| Tonna, M | 1 |
| Maggini, C | 1 |
| Yamamoto, N | 1 |
| Oda, T | 1 |
| Inada, T | 1 |
| Lee, J | 1 |
| Teoh, T | 1 |
| Lee, TS | 1 |
| Chouinard, G | 1 |
| Vainer, JL | 1 |
| Bélanger, MC | 1 |
| Turnier, L | 1 |
| Beaudry, P | 1 |
| Roy, JY | 1 |
| Miller, R | 1 |
| Rich, SS | 1 |
| Friedman, JH | 1 |
| Ott, BR | 1 |
| Damecour, CL | 1 |
| Turcotte, JR | 1 |
| Misra, L | 1 |
| Kofoed, L | 3 |
| Meco, G | 1 |
| Alessandri, A | 1 |
| Giustini, P | 1 |
| Bonifati, V | 1 |
| Brimstedt, L | 1 |
| Lane, HY | 1 |
| Chang, WH | 1 |
| Sekine, Y | 1 |
| Matsunaga, T | 1 |
| Tsukamoto, T | 1 |
| Takei, N | 1 |
| Mori, N | 1 |
| Gabbert, JF | 1 |
| Giannini, AJ | 1 |
| Misra, LK | 2 |
| Fuller, W | 1 |
| Jha, A | 1 |
| Fourie, H | 1 |
| Kramer, TM | 1 |
| Cottingham, EM | 1 |
| Leopold, NA | 1 |
| Duggal, HS | 1 |
| Nizamie, SH | 1 |
| Oesterheld, JR | 1 |
| Richards, GA | 1 |
| Mohr, E | 1 |
| Mendis, T | 1 |
| Hildebrand, K | 1 |
| De Deyn, PP | 1 |
| Terao, T | 1 |
| Kojima, H | 1 |
| DeSilva, CC | 1 |
| Nurse, MC | 1 |
| Vokey, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Open-Label Trial Exploring A Switching Regimen From Oral Neuroleptics, Other Than Risperidone, To Risperidone Depot Microspheres[NCT00034775] | Phase 3 | 141 participants (Actual) | Interventional | 2001-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for risperidone and Psychoses, Drug
| Article | Year |
|---|---|
Men and women respond differently to antipsychotic drugs.
Topics: Antipsychotic Agents; Clozapine; Female; Humans; Male; Olanzapine; Psychoses, Substance-Induced; Psy | 2020 |
8 trials available for risperidone and Psychoses, Drug
| Article | Year |
|---|---|
Aripiprazole and Risperidone Present Comparable Long-Term Metabolic Profiles: Data From a Pragmatic Randomized Controlled Trial in Drug-Naïve First-Episode Psychosis.
Topics: Antipsychotic Agents; Aripiprazole; Humans; Lipids; Metabolome; Psychoses, Substance-Induced; Psycho | 2022 |
Randomized controlled trial of aripiprazole versus risperidone for the treatment of amphetamine-induced psychosis.
Topics: Adolescent; Adult; Amphetamine; Antipsychotic Agents; Aripiprazole; Double-Blind Method; Female; Hum | 2014 |
Aripiprazole and Risperidone for Treatment of Methamphetamine-Associated Psychosis in Chinese Patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; China; Female; Humans; Male; Middle Aged; Psy | 2016 |
Dopaminergic modulation of rapid reality adaptation in thinking.
Topics: Adaptation, Psychological; Adult; Brain; Cognition Disorders; Dopamine; Dopamine Agents; Dopamine An | 2010 |
Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Diarrhea; Drug Administration Schedule; Dr | 2004 |
Risperidone and clozapine in the treatment of drug-resistant schizophrenia and neuroleptic-induced supersensitivity psychosis.
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Resistance; Dyskinesia, Drug-Induced; Female; Haloperid | 1994 |
Risperidone in levodopa-induced psychosis in advanced Parkinson's disease: an open-label, long-term study.
Topics: Aged; Antipsychotic Agents; Disease Progression; Female; Follow-Up Studies; Humans; Levodopa; Male; | 1997 |
Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: an open pilot trial.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Belgium; Canada; Dopamin | 2000 |
45 other studies available for risperidone and Psychoses, Drug
| Article | Year |
|---|---|
Design, Synthesis, and Pharmacological Evaluation of 5,6-Disubstituted Pyridin-2(1H)-one Derivatives as Phosphodiesterase 10A (PDE10A) Antagonists.
Topics: Acetates; Animals; Antipsychotic Agents; Area Under Curve; Dogs; Drug Design; Female; Glucuronides; | 2015 |
Acetyl-l-Carnitine and New-Onset Psychosis During the COVID-19 Pandemic.
Topics: Acetylcarnitine; Antipsychotic Agents; COVID-19; Delusions; Dietary Supplements; Humans; Male; Middl | 2020 |
Functional foods: How functional are they? A case report of supplement-induced psychosis.
Topics: Adult; Antipsychotic Agents; Bromelains; Chlorella; Dietary Supplements; Female; Functional Food; Hu | 2016 |
Metabolism of risperidone by CYP2D6 and the presence of drug-induced dopamine supersensitivity psychosis in patients with schizophrenia.
Topics: Alleles; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Dopamine; Genotype; Humans; Paliperidone Pal | 2019 |
Alcohol-induced psychotic disorder in a 42-year-old female patient.
Topics: Adult; Alcoholism; Antipsychotic Agents; Female; Humans; Psychoses, Substance-Induced; Risperidone | 2013 |
MK-801, a NMDA receptor antagonist, increases phosphorylation of histone H3 in the rat medial prefrontal cortex.
Topics: Acetylation; Animals; Antipsychotic Agents; Chromatin Assembly and Disassembly; Dizocilpine Maleate; | 2013 |
Tramadol-related psychosis in a patient with bipolar I disorder.
Topics: Analgesics, Opioid; Antipsychotic Agents; Bipolar Disorder; Delusions; Drug Interactions; Female; Hu | 2015 |
Risperidone exacerbates Psychosis: A paradoxical phenomenon?
Topics: Antipsychotic Agents; Humans; Hydrocephalus; Male; Psychoses, Substance-Induced; Psychotic Disorders | 2015 |
Risperidone long-acting injectable in the treatment of treatment-resistant schizophrenia with dopamine supersensitivity psychosis: Results of a 2-year prospective study, including an additional 1-year follow-up.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Chlorpromazine; Delayed-Action Preparations; Dopamine | 2016 |
Case of acute psychosis from herbal supplements.
Topics: Acute Disease; Adult; Antipsychotic Agents; Dietary Supplements; Female; Haloperidol; Humans; Loraze | 2008 |
Sibutramine-induced psychotic episode in an adolescent.
Topics: Adolescent; Antipsychotic Agents; Cyclobutanes; Humans; Kleine-Levin Syndrome; Male; Obesity; Psycho | 2008 |
Childhood mefloquine-induced mania and psychosis: a case report.
Topics: Antimalarials; Antipsychotic Agents; Bipolar Disorder; Child; Female; Follow-Up Studies; Humans; Mal | 2009 |
Postoperative psychosis in an adolescent subsequent to oral surgical outpatient procedure.
Topics: Antipsychotic Agents; Dexamethasone; Female; Glucocorticoids; Humans; Injections, Intravenous; Loraz | 2009 |
Organic psychosis induced by ofloxacin and metronidazole.
Topics: Adolescent; Anti-Infective Agents; Antipsychotic Agents; Citalopram; Drug Therapy, Combination; Fema | 2009 |
Persistent psychosis associated with salvia divinorum use.
Topics: Antipsychotic Agents; Camphanes; Drugs, Chinese Herbal; Humans; Male; Panax notoginseng; Psychoses, | 2009 |
Radioactive iodine-induced psychosis.
Topics: Adult; Antipsychotic Agents; Female; Humans; Iodine Radioisotopes; Psychoses, Substance-Induced; Ris | 2009 |
Concurrent treatment of steroid-related mood and psychotic symptoms with risperidone.
Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Hormonal; Antipsychotic Agents; Child; Dexa | 2010 |
Psychosis associated with switching from risperidone to aripiprazole in an adolescent on methylphenidate treatment.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Central Nervous System Stimulants; Humans; Male; Met | 2011 |
Dexamethasone induced psychosis presenting with catatonic features.
Topics: Adult; Antipsychotic Agents; Catatonia; Dexamethasone; Diazepam; Female; Follow-Up Studies; GABA Mod | 2011 |
Severe psychotic exacerbation during combined treatment with aripiprazole/haloperidol after prior treatment with risperidone.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Drug Combinations; Drug Interactions; Female; Haloperidol | 2012 |
[Designer drug induced psychosis].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Benzodioxoles; Clonazepam; Designer Drugs; Drug Therap | 2012 |
Metoclopramide-induced supersensitivity psychosis.
Topics: Aged; Antiemetics; Antipsychotic Agents; Diabetes Mellitus, Type 2; Drug Hypersensitivity; Hallucina | 2002 |
Risperidone-induced rabbit syndrome in mood disorder.
Topics: Antipsychotic Agents; Depressive Disorder, Major; Diagnosis, Differential; Hallucinations; Humans; M | 2004 |
The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis.
Topics: Adult; Antipsychotic Agents; Australia; Benzodiazepines; Cohort Studies; Disease Progression; Female | 2005 |
Risperidone-induced psychosis and depression in a child with a mitochondrial disorder.
Topics: Adolescent; Depressive Disorder; Epilepsy, Tonic-Clonic; Female; Humans; Mitochondrial Diseases; Moo | 2005 |
[Psychiatric illness associated with amphetamines and other stimulants].
Topics: Adult; Amnesia; Amphetamines; Central Nervous System Stimulants; Cognition Disorders; Designer Drugs | 2000 |
Psychosis during peginterferon-alpha 2a and ribavirin therapy: case report.
Topics: Antipsychotic Agents; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Int | 2006 |
Obsessive-compulsive disorder followed by psychotic episode in long-term ecstasy misuse.
Topics: Adolescent; Amphetamine-Related Disorders; Antidepressive Agents, Tricyclic; Antipsychotic Agents; B | 2009 |
Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam.
Topics: Aged; Anti-Dyskinesia Agents; Antipsychotic Agents; Benzodiazepines; Biperiden; Central Nervous Syst | 2007 |
Catatonia and psychosis associated with sibutramine: a case report and pathophysiologic correlation.
Topics: Adult; Antipsychotic Agents; Appetite Depressants; Body Image; Body Weight; Catatonia; Cyclobutanes; | 2008 |
Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes.
Topics: Aged; Antiparkinson Agents; Clozapine; Dyskinesia, Drug-Induced; Humans; Male; Parkinson Disease; Pa | 1995 |
Therapeutic dilemma: psychosis and Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Lev | 1995 |
Risperidone treatment of methamphetamine psychosis.
Topics: Drug Administration Schedule; Humans; Male; Methamphetamine; Middle Aged; Psychoses, Substance-Induc | 1997 |
[Is risperidone the right choice in severe substance-related psychoses?].
Topics: Antipsychotic Agents; Humans; Psychoses, Substance-Induced; Risperidone | 1998 |
Manic and psychotic symptoms following risperidone withdrawal in a schizophrenic patient.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Chronic Disease; Humans; Male; Psychoses, Substance-I | 1998 |
Methamphetamine-associated obsessional symptoms and effective risperidone treatment: a case report.
Topics: Adult; Dopamine Antagonists; Humans; Male; Methamphetamine; Obsessive-Compulsive Disorder; Psychoses | 1999 |
Clinical Therapeutic Conference: dopaminergic/serotonergic actions of phencyclidine as a model for schizophreniform psychosis.
Topics: Adult; Female; Hallucinogens; Humans; Male; Models, Psychological; Phencyclidine; Psychoses, Substan | 1997 |
Treatment of inhalant abuse with risperidone.
Topics: Administration, Inhalation; Adult; Gasoline; Humans; Male; Petroleum; Psychoses, Substance-Induced; | 1999 |
Risperidone treatment of amphetamine psychosis.
Topics: Aged; Amphetamine; Antipsychotic Agents; Central Nervous System Stimulants; Female; Humans; Psychose | 1999 |
Risperidone in the treatment of steroid-induced psychosis.
Topics: Adolescent; Adrenal Cortex Hormones; Antipsychotic Agents; Female; Humans; Psychoses, Substance-Indu | 1999 |
Risperidone treatment of drug-related psychosis in patients with parkinsonism.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Female; Hallucinations; Humans; | 2000 |
Novel antipsychotic drugs and INH-related psychosis.
Topics: Adolescent; Antipsychotic Agents; Antitubercular Agents; Bipolar Disorder; Humans; Isoniazid; Lithiu | 2000 |
Olanzapine treatment of methamphetamine psychosis.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Central Nervous System Stimulants; Humans; Male; Metha | 2000 |
Risperidone addition and psychotic exacerbation.
Topics: Delusions; Drug Therapy, Combination; Humans; Male; Middle Aged; Psychoses, Substance-Induced; Psych | 2001 |
Steroid-induced psychosis treated with risperidone.
Topics: Adult; Antipsychotic Agents; Asthma; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Pred | 2002 |